Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short UA Q1 2026 Earnings EPS Misses Estimates as Turnaround Efforts Continue CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 CLNN Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Neurological Pipeline MWA Q1 2026 Earnings EPS Beats Estimates by 647